Its therapeutic effect on hyperglycemia was evidenced by the reduction of blood glucose, serum insulin levels and HOMA-IR index while improving glucose tolerance and insulin sensitivity in skeletal muscle of db/db mice via activating insulin signaling PI3K/AKT pathway (Liu et al., 2015). The gene discussed is AKT1; the disease is Hyperglycemia.